US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Rapport Therapeutics, Inc.

29.50

-0.7000-2.32%

Post-market: 29.500.00000.00%16:10 EST

Volume:163.65K

Turnover:4.78M

Market Cap:1.41B

PE:-10.86

High:30.34

Open:30.34

Low:28.26

Close:30.20

52wk High:42.27

52wk Low:6.43

Shares:47.66M

Float Shares:26.57M

Volume Ratio:0.54

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7168

EPS(LYR):-3.7760

ROE:-23.41%

ROA:-15.89%

PB:2.75

PE(LYR):-7.81

Loading ...

Overview Company News Filings

Rapport Therapeutics price target raised to $80 from $77 at Citizens JMP

Promising Phase II Results and Strong Financial Position Drive Buy Rating for Rapport Therapeutics

H.C. Wainwright Remains a Buy on Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics reports Q3 EPS (71c), consensus (73c)

Rapport Therapeutics Q3 EPS $(0.71) Beats $(0.77) Estimate

Rapport Therapeutics: Phase 2 Trial of Rap-219 on Track, Topline Results Expected in First Half of 2027

THOMSON REUTERS

Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update

THOMSON REUTERS

Biotech Stocks Are Coming Back. Here's What's Driving The Sector Higher.

Biotech is back. Here's why these rallying stocks belong in your portfolio now.

Rapport Therapeutics Inc expected to post a loss of 78 cents a share - Earnings Preview

Rapport Therapeutics CEO Abraham Ceesay Reports Disposal of Common Shares

Citizens JMP Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)

CEO Abraham Ceesay Reports Disposal of Common Shares in Rapport Therapeutics Inc

Rapport Therapeutics Initiated at Buy by Truist Securities

Truist Initiates Rapport Therapeutics at Buy With $44 Price Target

MT Newswires Live

Rapport Therapeutics director buys $1.03M in common stock

Director Reid M. Huber Reports Acquisition of Common Shares in Rapport Therapeutics Inc

Analysts Are Bullish on Top NA Stocks: Rubrik, Inc. Class A (RBRK), Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics assigned Buy rating at Goldman Sachs

Director’s Bold Move: Major Stock Purchase at Rapport Therapeutics!

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RAPP/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":29.5,"timestamp":1772139600000,"preClose":30.2,"halted":0,"volume":163645,"hourTrading":{"tag":"盘后","latestPrice":29.5,"preClose":29.5,"latestTime":"16:10 EST","volume":4990,"amount":147205.46407,"timestamp":1772140204334,"change":0,"changeRate":0,"amplitude":0.000339},"delay":0,"changeRate":-0.023178807947019844,"floatShares":26567199,"shares":47661138,"eps":-2.716762,"marketStatus":"Post-Mkt","change":-0.7,"latestTime":"02-26 18:18:00 EST","open":30.34,"high":30.34,"low":28.255,"amount":4776486.3756,"amplitude":0.06904,"askPrice":30.08,"askSize":66,"bidPrice":28.93,"bidSize":69,"shortable":3,"etf":0,"ttmEps":-2.716762,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1772154000000},"marketStatusCode":4,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":30.2,"postHourTrading":{"tag":"盘后","latestPrice":29.5,"preClose":29.5,"latestTime":"16:10 EST","volume":4990,"amount":147205.46407,"timestamp":1772140204334,"change":0,"changeRate":0,"amplitude":0.000339},"volumeRatio":0.535296,"impliedVol":1.0256,"impliedVolPercentile":0.7092},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","floatShares":26567199,"roa":"-15.89%","roe":"-23.41%","lyrEps":-3.775953,"volumeRatio":0.535296,"shares":47661138,"dividePrice":0,"high":30.34,"amplitude":0.06904,"preClose":30.2,"low":28.255,"week52Low":6.43,"pbRate":"2.75","week52High":42.2685,"institutionHeld":0,"latestPrice":29.5,"committee":0.022222,"eps":-2.716762,"divideRate":0,"volume":163645,"delay":0,"ttmEps":-2.716762,"open":30.34,"prevYearClose":30.34,"prevWeekClose":29.76,"prevMonthClose":26.61,"prevQuarterClose":30.34,"fiveDayClose":29.99,"twentyDayClose":26.44,"sixtyDayClose":29.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAPP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"RAPP","fiscalQuarterEnding":"2025/09","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2025-08-07","symbol":"RAPP","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.75},{"market":"US","date":"2025-05-08","symbol":"RAPP","fiscalQuarterEnding":"2025/03","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2025-03-11","symbol":"RAPP","fiscalQuarterEnding":"2024/12","expectedEps":-0.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.57},{"market":"US","date":"2024-11-07","symbol":"RAPP","fiscalQuarterEnding":"2024/09","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAPP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAPP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.7,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7,"analysts":10,"updateTime":1771045200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAPP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAPP","date":"2026-02-25","current":-10.858515,"percent":0.204176,"low":-19.654107,"twenty":-14.172361,"median":-11.478499,"eighty":-5.69117,"high":-3.640031,"avg":-10.448937,"sd":4.090439,"marketCap":1381696390},"quantilePoints":[{"date":"2024-06-07","current":-14.341434,"twenty":-13.293406,"median":-11.721364,"eighty":-11.721364,"marketCap":735830305},{"date":"2024-06-14","current":-17.322989,"twenty":-16.966549,"median":-15.024031,"eighty":-12.769392,"marketCap":888807905},{"date":"2024-06-21","current":-15.733266,"twenty":-17.881887,"median":-15.772475,"eighty":-14.348329,"marketCap":807242405},{"date":"2024-06-28","current":-16.581593,"twenty":-17.17471,"median":-16.18238,"eighty":-14.635158,"marketCap":850768389},{"date":"2024-07-05","current":-17.059223,"twenty":-17.829134,"median":-16.431888,"eighty":-15.672154,"marketCap":875274616},{"date":"2024-07-12","current":-18.299635,"twenty":-18.057796,"median":-16.595851,"eighty":-15.733266,"marketCap":938917651},{"date":"2024-07-19","current":-14.343149,"twenty":-18.092899,"median":-16.610109,"eighty":-15.733266,"marketCap":735918314},{"date":"2024-07-26","current":-16.431888,"twenty":-18.057796,"median":-16.50674,"eighty":-14.592658,"marketCap":843087333},{"date":"2024-08-02","current":-15.740395,"twenty":-18.021611,"median":-16.417631,"eighty":-14.614044,"marketCap":807608170},{"date":"2024-08-09","current":-11.062669,"twenty":-17.829134,"median":-16.189509,"eighty":-14.507112,"marketCap":697147270},{"date":"2024-08-16","current":-12.078391,"twenty":-17.822005,"median":-15.897228,"eighty":-14.341434,"marketCap":761156070},{"date":"2024-08-23","current":-12.943207,"twenty":-17.322989,"median":-15.776039,"eighty":-12.769083,"marketCap":815654991},{"date":"2024-08-30","current":-12.623979,"twenty":-17.301602,"median":-15.672154,"eighty":-12.252515,"marketCap":795537939},{"date":"2024-09-06","current":-11.799793,"twenty":-17.107699,"median":-14.956226,"eighty":-12.030797,"marketCap":743599370},{"date":"2024-09-13","current":-11.027844,"twenty":-17.007896,"median":-14.603351,"eighty":-11.813723,"marketCap":694952683},{"date":"2024-09-20","current":-12.322165,"twenty":-16.6871,"median":-14.421566,"eighty":-11.752199,"marketCap":776518182},{"date":"2024-09-27","current":-12.380206,"twenty":-16.587296,"median":-14.342291,"eighty":-11.752199,"marketCap":780175827},{"date":"2024-10-04","current":-12.072587,"twenty":-16.581593,"median":-13.041877,"eighty":-11.742318,"marketCap":760790305},{"date":"2024-10-11","current":-12.798103,"twenty":-16.461829,"median":-12.783593,"eighty":-11.721364,"marketCap":806510876},{"date":"2024-10-18","current":-15.061713,"twenty":-16.461829,"median":-13.041877,"eighty":-11.742318,"marketCap":949159059},{"date":"2024-10-25","current":-14.057599,"twenty":-16.431888,"median":-14.106934,"eighty":-11.752199,"marketCap":885881788},{"date":"2024-11-01","current":-14.289764,"twenty":-16.420482,"median":-14.289764,"eighty":-11.78122,"marketCap":900512371},{"date":"2024-11-08","current":-13.587752,"twenty":-16.360601,"median":-14.196898,"eighty":-11.792828,"marketCap":976225637},{"date":"2024-11-15","current":-10.665545,"twenty":-16.293733,"median":-13.709352,"eighty":-11.752199,"marketCap":766276774},{"date":"2024-11-22","current":-11.755009,"twenty":-16.213426,"median":-13.641207,"eighty":-11.719637,"marketCap":844550392},{"date":"2024-11-29","current":-11.627735,"twenty":-16.188083,"median":-13.405914,"eighty":-11.573511,"marketCap":835406277},{"date":"2024-12-06","current":-10.416089,"twenty":-16.139607,"median":-12.943207,"eighty":-11.450385,"marketCap":748354310},{"date":"2024-12-13","current":-9.555718,"twenty":-15.982774,"median":-12.73716,"eighty":-11.371152,"marketCap":686540097},{"date":"2024-12-20","current":-9.199351,"twenty":-15.858733,"median":-12.415031,"eighty":-11.254059,"marketCap":660936577},{"date":"2024-12-27","current":-9.688083,"twenty":-15.824515,"median":-12.350651,"eighty":-11.045256,"marketCap":696049976},{"date":"2025-01-03","current":-9.917175,"twenty":-15.797425,"median":-12.316361,"eighty":-10.975704,"marketCap":712509382},{"date":"2025-01-10","current":-7.539701,"twenty":-15.740395,"median":-12.304752,"eighty":-10.859002,"marketCap":541697328},{"date":"2025-01-17","current":-6.460419,"twenty":-15.733266,"median":-12.215086,"eighty":-10.644772,"marketCap":464155239},{"date":"2025-01-24","current":-7.076424,"twenty":-15.684376,"median":-12.087097,"eighty":-10.43238,"marketCap":508412752},{"date":"2025-01-31","current":-8.354253,"twenty":-15.597056,"median":-11.915876,"eighty":-10.137105,"marketCap":600219659},{"date":"2025-02-07","current":-8.211706,"twenty":-15.257893,"median":-11.843324,"eighty":-9.686047,"marketCap":589978251},{"date":"2025-02-14","current":-8.094614,"twenty":-15.103195,"median":-11.828814,"eighty":-9.441681,"marketCap":581565666},{"date":"2025-02-21","current":-6.455328,"twenty":-15.070846,"median":-11.799793,"eighty":-9.297098,"marketCap":463789474},{"date":"2025-02-28","current":-5.106225,"twenty":-15.037336,"median":-11.771597,"eighty":-9.077168,"marketCap":366861863},{"date":"2025-03-07","current":-4.373128,"twenty":-15.01412,"median":-11.747556,"eighty":-8.771711,"marketCap":314191765},{"date":"2025-03-14","current":-4.898381,"twenty":-14.977526,"median":-11.717047,"eighty":-8.416363,"marketCap":383577552},{"date":"2025-03-21","current":-4.530187,"twenty":-14.817535,"median":-11.627735,"eighty":-8.164869,"marketCap":354745367},{"date":"2025-03-28","current":-4.68399,"twenty":-14.676319,"median":-11.461087,"eighty":-7.790176,"marketCap":366789191},{"date":"2025-04-04","current":-4.189957,"twenty":-14.640334,"median":-11.410917,"eighty":-7.133443,"marketCap":328102968},{"date":"2025-04-11","current":-4.315796,"twenty":-14.632186,"median":-11.370643,"eighty":-6.989878,"marketCap":337957006},{"date":"2025-04-17","current":-4.730597,"twenty":-14.622599,"median":-11.327444,"eighty":-6.74653,"marketCap":370438835},{"date":"2025-04-25","current":-4.949801,"twenty":-14.60549,"median":-11.189913,"eighty":-6.457364,"marketCap":387604034},{"date":"2025-05-02","current":-5.280719,"twenty":-14.55844,"median":-11.048158,"eighty":-5.528775,"marketCap":413517298},{"date":"2025-05-09","current":-4.693792,"twenty":-14.472894,"median":-10.976093,"eighty":-5.332796,"marketCap":374099938},{"date":"2025-05-16","current":-4.560992,"twenty":-14.4176,"median":-10.940782,"eighty":-5.2164,"marketCap":363515647},{"date":"2025-05-23","current":-5.092192,"twenty":-14.397354,"median":-10.8247,"eighty":-5.097805,"marketCap":405852811},{"date":"2025-05-30","current":-3.896992,"twenty":-14.370288,"median":-10.665545,"eighty":-4.981023,"marketCap":310594193},{"date":"2025-06-06","current":-5.646289,"twenty":-14.346875,"median":-10.527934,"eighty":-4.950803,"marketCap":450014853},{"date":"2025-06-13","current":-5.101351,"twenty":-14.342806,"median":-10.416089,"eighty":-4.981023,"marketCap":406582762},{"date":"2025-06-20","current":-5.050978,"twenty":-14.341434,"median":-10.309179,"eighty":-5.014344,"marketCap":402568031},{"date":"2025-06-27","current":-5.408165,"twenty":-14.289764,"median":-9.866266,"eighty":-5.000606,"marketCap":431036124},{"date":"2025-07-03","current":-5.513507,"twenty":-14.247974,"median":-9.698265,"eighty":-5.011596,"marketCap":439432031},{"date":"2025-07-11","current":-7.043002,"twenty":-14.172521,"median":-9.586263,"eighty":-5.043651,"marketCap":561334272},{"date":"2025-07-18","current":-6.795718,"twenty":-14.077333,"median":-9.430989,"eighty":-5.078884,"marketCap":541625526},{"date":"2025-07-25","current":-7.610838,"twenty":-13.779001,"median":-9.362262,"eighty":-5.090926,"marketCap":606591391},{"date":"2025-08-01","current":-6.57591,"twenty":-13.6976,"median":-9.168805,"eighty":-5.092192,"marketCap":524106641},{"date":"2025-08-08","current":-6.368661,"twenty":-13.694662,"median":-9.054259,"eighty":-5.099519,"marketCap":562429202},{"date":"2025-08-15","current":-6.17446,"twenty":-13.609134,"median":-8.982986,"eighty":-5.10525,"marketCap":545278924},{"date":"2025-08-22","current":-6.170327,"twenty":-13.473486,"median":-8.4968,"eighty":-5.115317,"marketCap":544913945},{"date":"2025-08-29","current":-6.943168,"twenty":-13.38251,"median":-8.407708,"eighty":-5.122916,"marketCap":613165056},{"date":"2025-09-05","current":-6.343907,"twenty":-13.171889,"median":-8.282979,"eighty":-5.126995,"marketCap":560243072},{"date":"2025-09-12","current":-9.588184,"twenty":-13.020376,"median":-8.364435,"eighty":-5.143059,"marketCap":846751744},{"date":"2025-09-19","current":-14.281097,"twenty":-13.398113,"median":-8.486618,"eighty":-5.165131,"marketCap":1261192245},{"date":"2025-09-26","current":-13.038354,"twenty":-13.650327,"median":-8.934622,"eighty":-5.176938,"marketCap":1151443158},{"date":"2025-10-03","current":-14.902468,"twenty":-13.718742,"median":-9.051713,"eighty":-5.195691,"marketCap":1316066789},{"date":"2025-10-10","current":-13.962579,"twenty":-13.896787,"median":-9.158623,"eighty":-5.223161,"marketCap":1233063277},{"date":"2025-10-17","current":-12.986138,"twenty":-13.856058,"median":-9.228454,"eighty":-5.262092,"marketCap":1146831851},{"date":"2025-10-24","current":-13.675391,"twenty":-13.856058,"median":-9.397898,"eighty":-5.294604,"marketCap":1207701093},{"date":"2025-10-31","current":-14.035682,"twenty":-13.934383,"median":-9.502263,"eighty":-5.303959,"marketCap":1239519106},{"date":"2025-11-07","current":-11.969573,"twenty":-13.970933,"median":-9.588184,"eighty":-5.319746,"marketCap":1169427252},{"date":"2025-11-14","current":-12.034803,"twenty":-13.934383,"median":-9.698265,"eighty":-5.33408,"marketCap":1175800274},{"date":"2025-11-21","current":-13.098276,"twenty":-13.915585,"median":-9.917175,"eighty":-5.342242,"marketCap":1279701555},{"date":"2025-11-28","current":-14.493474,"twenty":-13.931568,"median":-10.309179,"eighty":-5.356195,"marketCap":1416012409},{"date":"2025-12-05","current":-14.000764,"twenty":-13.954437,"median":-10.426271,"eighty":-5.376155,"marketCap":1367874660},{"date":"2025-12-12","current":-14.039791,"twenty":-13.99491,"median":-10.604143,"eighty":-5.393122,"marketCap":1371687551},{"date":"2025-12-19","current":-14.459326,"twenty":-14.050476,"median":-10.719003,"eighty":-5.431972,"marketCap":1412676130},{"date":"2025-12-26","current":-15.088628,"twenty":-14.119227,"median":-10.841851,"eighty":-5.476848,"marketCap":1474158998},{"date":"2026-01-02","current":-14.800808,"twenty":-14.281097,"median":-10.940782,"eighty":-5.513507,"marketCap":1446038926},{"date":"2026-01-09","current":-13.81051,"twenty":-14.281097,"median":-10.976093,"eighty":-5.513507,"marketCap":1349286816},{"date":"2026-01-16","current":-13.103154,"twenty":-14.237527,"median":-11.048158,"eighty":-5.513507,"marketCap":1280178166},{"date":"2026-01-23","current":-13.620256,"twenty":-14.172521,"median":-11.156822,"eighty":-5.535473,"marketCap":1330698972},{"date":"2026-01-30","current":-13.049493,"twenty":-14.13499,"median":-11.312246,"eighty":-5.592253,"marketCap":1274935441},{"date":"2026-02-06","current":-12.464095,"twenty":-14.128014,"median":-11.370643,"eighty":-5.617345,"marketCap":1217742075},{"date":"2026-02-13","current":-13.644647,"twenty":-14.087483,"median":-11.410917,"eighty":-5.641114,"marketCap":1333082029},{"date":"2026-02-20","current":-14.630067,"twenty":-14.14031,"median":-11.45735,"eighty":-5.660027,"marketCap":1429357528},{"date":"2026-02-25","current":-14.142235,"twenty":-14.172361,"median":-11.478499,"eighty":-5.69117,"marketCap":1381696390}],"updateTime":1772147881008},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAPP\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581009530","title":"Rapport Therapeutics price target raised to $80 from $77 at Citizens JMP","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009530?lang=en_us&edition=fundamental","pubTime":"2025-11-07 18:50","pubTimestamp":1762512653,"startTime":"0","endTime":"0","summary":"Citizens JMP raised the firm’s price target on Rapport Therapeutics (RAPP) to $80 from $77 and keeps an Outperform rating on the shares. Rapport re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-price-target-raised-to-80-from-77-at-citizens-jmp-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-price-target-raised-to-80-from-77-at-citizens-jmp-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP","JMP"],"gpt_icon":0},{"id":"2581018167","title":"Promising Phase II Results and Strong Financial Position Drive Buy Rating for Rapport Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2581018167","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581018167?lang=en_us&edition=fundamental","pubTime":"2025-11-07 00:25","pubTimestamp":1762446328,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Joseph Thome has maintained their bullish stance on RAPP stock, giving a Buy rating today. Joseph Thome has given his Buy rating d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-ii-results-and-strong-financial-position-drive-buy-rating-for-rapport-therapeutics-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-ii-results-and-strong-financial-position-drive-buy-rating-for-rapport-therapeutics-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP"],"gpt_icon":0},{"id":"2581660090","title":"H.C. Wainwright Remains a Buy on Rapport Therapeutics, Inc. (RAPP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581660090","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581660090?lang=en_us&edition=fundamental","pubTime":"2025-11-06 23:56","pubTimestamp":1762444601,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Rapport Therapeutics, Inc. today and set a price target of $34.00. Tsao covers the ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-rapport-therapeutics-inc-rapp-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-rapport-therapeutics-inc-rapp-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2581067105","title":"Rapport Therapeutics reports Q3 EPS (71c), consensus (73c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581067105","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581067105?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:13","pubTimestamp":1762431180,"startTime":"0","endTime":"0","summary":"“The positive Phase 2a results for RAP-219 announced in September underscore both the strength of our precision neuroscience platform and the compo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-reports-q3-eps-71c-consensus-73c-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-reports-q3-eps-71c-consensus-73c-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP"],"gpt_icon":0},{"id":"2581062045","title":"Rapport Therapeutics Q3 EPS $(0.71) Beats $(0.77) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581062045","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581062045?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:11","pubTimestamp":1762431076,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics (NASDAQ:RAPP) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.77) by 7.19 percent. This is a 42 percent decrease over losses of $(0.50) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48682606/rapport-therapeutics-q3-eps-0-71-beats-0-77-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP"],"gpt_icon":0},{"id":"2581674080","title":"Rapport Therapeutics: Phase 2 Trial of Rap-219 on Track, Topline Results Expected in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2581674080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581674080?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430411,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA6MGS7N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2581064291","title":"Rapport Therapeutics Reports Third Quarter 2025 Financials and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2581064291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581064291?lang=en_us&edition=fundamental","pubTime":"2025-11-06 20:00","pubTimestamp":1762430411,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUA6MGS7N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2580759232","title":"Biotech Stocks Are Coming Back. Here's What's Driving The Sector Higher.","url":"https://stock-news.laohu8.com/highlight/detail?id=2580759232","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580759232?lang=en_us&edition=fundamental","pubTime":"2025-11-04 10:55","pubTimestamp":1762224956,"startTime":"0","endTime":"0","summary":"Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a8e8b2c49707183fd768f0d17d08b819","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1814569148.SGD","MBX","LU0471298777.SGD","LU2347655156.SGD","BBIO","PFE","RAPP","ASND","SG9999003800.SGD","LU1868837300.USD","LU2087625088.SGD","SG9999013999.USD","PRAX","IE00BLSP4239.USD","LLY","MDGL","LU0985481810.HKD","QURE","SG9999014906.USD","LU0795875169.SGD","LU1868836591.USD","AMGN","SG9999015952.SGD","IE00BWXC8680.SGD","LU0154245673.USD","LU0211327993.USD","LU1267930573.SGD","SG9999001176.USD","LU1868837136.USD","ARGX","BMY","ALNY","LU0965509283.SGD","LU0170899867.USD","IE0002141913.USD","LU2264538146.SGD","LU0006306889.USD","LU1074936037.SGD","NBIX","LU0672654240.SGD","IE00BFXG1179.USD","LU1868836914.USD","LU1868836757.USD","IE00BN8TJ469.HKD","IE00BBT3K403.USD","IE0009355771.USD","LU1548497426.USD","LU1291159041.SGD","ALKS","ABBV"],"gpt_icon":1},{"id":"2580214052","title":"Biotech is back. Here's why these rallying stocks belong in your portfolio now.","url":"https://stock-news.laohu8.com/highlight/detail?id=2580214052","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580214052?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:58","pubTimestamp":1762181880,"startTime":"0","endTime":"0","summary":"The volatile sector is seeing greater stability, and these four stocks can profit. Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 percentage points.Biotech's strength is likely to continue - so it's not too late for investors to get in, sector analysts say.\"Biotech will be a comparative outperformer,\" says Motley Fool biotech analyst Karl Thiel. \"There is better sentiment and fund-flow, and that feeds on itself. That can unravel quickly but I still think it has some legs.\". Stifel's head of biotech research, Paul Matteis, agrees. \"The sector's run has been driven by a number of credible fundamental factors that seem mostly sustainable,\" he said in a recent interview.M&A also puts higher valuations on biotech companies in general because investors start considering how much more profitable potential drugs might be in the hands of companies ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU0238689110.USD","LU0124676726.USD","LU0109391861.USD","LU2461242641.AUD","ARGX","MDGL","BBIO","PRAX","ALNY","ALKS","BMY","LU0545039389.USD","IE00B1XK9C88.USD","LU2491050071.SGD","BK4533","LU1066053197.SGD","LU0310799852.SGD","LU1670711123.USD","MBX","ASND","GB00BDT5M118.USD","LU1670710588.SGD","LU2237443978.SGD","RAPP","AMGN","ABBV","QURE","LU1162221912.USD","LU0097036916.USD","LU2237443382.USD","LU2491049909.HKD","LU0965508806.USD","BK4534","LU1366192091.USD","LU1267930730.SGD","LU2357305700.SGD","LU2237443622.USD","LU0661504455.SGD","LU1670710661.SGD","LU2065170008.USD","LU0985320562.USD","LU2129689605.HKD","LU0471298694.HKD","LU2237443549.SGD","LU1093756325.SGD","LU2491050154.USD","NBIX"],"gpt_icon":1},{"id":"2580121509","title":"Rapport Therapeutics Inc  expected to post a loss of 78 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580121509","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580121509?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:37","pubTimestamp":1762177027,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Inc  expected to post a loss of78cents a share - Earnings Preview Rapport Therapeutics Inc RAPP.OQ RAPP.O is expected to  show no change in quarterly revenue when it reports  resu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF15D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2576777343","title":"Rapport Therapeutics CEO Abraham Ceesay Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2576777343","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576777343?lang=en_us&edition=fundamental","pubTime":"2025-10-17 04:30","pubTimestamp":1760646643,"startTime":"0","endTime":"0","summary":"Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 16, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL3yb6GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2569725089","title":"Citizens JMP Sticks to Their Buy Rating for Rapport Therapeutics, Inc. (RAPP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2569725089","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569725089?lang=en_us&edition=fundamental","pubTime":"2025-09-24 10:05","pubTimestamp":1758679510,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jason Butler from Citizens JMP reiterated a Buy rating on Rapport Therapeutics, Inc., with a price target of $77.00...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citizens-jmp-sticks-to-their-buy-rating-for-rapport-therapeutics-inc-rapp-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citizens-jmp-sticks-to-their-buy-rating-for-rapport-therapeutics-inc-rapp-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JMP","RAPP"],"gpt_icon":0},{"id":"2569712877","title":"CEO Abraham Ceesay Reports Disposal of Common Shares in Rapport Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2569712877","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569712877?lang=en_us&edition=fundamental","pubTime":"2025-09-24 00:25","pubTimestamp":1758644733,"startTime":"0","endTime":"0","summary":"Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL67x2x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2567486066","title":"Rapport Therapeutics Initiated at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2567486066","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567486066?lang=en_us&edition=fundamental","pubTime":"2025-09-16 22:50","pubTimestamp":1758034200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RAPP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 16, 2025 10:50 ET (14:50 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"gpt_icon":0},{"id":"2567507109","title":"Truist Initiates Rapport Therapeutics at Buy With $44 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2567507109","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567507109?lang=en_us&edition=fundamental","pubTime":"2025-09-16 18:38","pubTimestamp":1758019093,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics (RAPP) has an average rating of buy and mean price target of $53, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RAPP"],"gpt_icon":0},{"id":"2567128997","title":"Rapport Therapeutics director buys $1.03M in common stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2567128997","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567128997?lang=en_us&edition=fundamental","pubTime":"2025-09-16 05:40","pubTimestamp":1757972412,"startTime":"0","endTime":"0","summary":"In a regulatory filing, Rapport Therapeutics (RAPP) disclosed that its director Steven Paul bought 41.7K shares of common stock on September 12th i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-director-buys-1-03m-in-common-stock-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-director-buys-1-03m-in-common-stock-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP","BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2567714244","title":"Director Reid M. Huber Reports Acquisition of Common Shares in Rapport Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2567714244","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567714244?lang=en_us&edition=fundamental","pubTime":"2025-09-16 04:05","pubTimestamp":1757966748,"startTime":"0","endTime":"0","summary":"Reid M. Huber, a Director at Rapport Therapeutics Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDL4yP16q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Director Reid M. Huber Reports Acquisition of Common Shares in Rapport Therapeutics Inc","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"gpt_icon":0},{"id":"2566920304","title":"Analysts Are Bullish on Top NA Stocks: Rubrik, Inc. Class A (RBRK), Rapport Therapeutics, Inc. (RAPP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2566920304","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566920304?lang=en_us&edition=fundamental","pubTime":"2025-09-12 17:30","pubTimestamp":1757669419,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Rubrik, Inc. Class A (RBRK – Research Report) and Rapport Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-rubrik-inc-class-a-rbrk-rapport-therapeutics-inc-rapp-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-na-stocks-rubrik-inc-class-a-rbrk-rapport-therapeutics-inc-rapp-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4097","BK4141","NA","BK4613","RAPP","RBRK","LU2286300806.USD","BK4112"],"gpt_icon":0},{"id":"2566920518","title":"Rapport Therapeutics assigned Buy rating at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2566920518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566920518?lang=en_us&edition=fundamental","pubTime":"2025-09-12 17:25","pubTimestamp":1757669115,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Salveen Richter assigned Rapport Therapeutics (RAPP) with a Buy rating and $51 price target from its Early-Stage Biotech desi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-assigned-buy-rating-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-assigned-buy-rating-at-goldman-sachs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","RAPP"],"gpt_icon":0},{"id":"2566949081","title":"Director’s Bold Move: Major Stock Purchase at Rapport Therapeutics!","url":"https://stock-news.laohu8.com/highlight/detail?id=2566949081","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566949081?lang=en_us&edition=fundamental","pubTime":"2025-09-12 10:12","pubTimestamp":1757643139,"startTime":"0","endTime":"0","summary":"New insider activity at Rapport Therapeutics, Inc. ( ($RAPP) ) has taken place on September 11, 2025. Director Wendy B. Young has made a significan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/directors-bold-move-major-stock-purchase-at-rapport-therapeutics-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/directors-bold-move-major-stock-purchase-at-rapport-therapeutics-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RAPP","BK4539","BK4007","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":102,"code":"91000000","status":"200"}]}}